Showing results (61-70 of 19,476) with videos related to
Sort By:
Pageof 1,948
International Journal of Clinical Practice|June 23, 2004
The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgeryA G G TurpieImmunology|September 18, 2008
Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cellsSharmila Masli, Bruce TurpieCurrent Opinion in Drug Discovery & Development|June 30, 2009
Direct Factor Xa and direct thrombin inhibitors: a clinical trial updateAlexander G G TurpieExpert Review of Cardiovascular Therapy|July 15, 2014
Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectivesAlexander G G TurpieClinical Cardiology|September 8, 2020
Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real-world prospective studyA John Camm, Pierre Amarenco, Sylvia Haas, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 28, 2018
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUSA John Camm, Pierre Amarenco, Sylvia Haas, et al.European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2018
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS studyPierre Amarenco, Sylvia Haas, Susanne Hess, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 28, 2024
Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUSPaulus Kirchhof, Sylvia Haas, Pierre Amarenco, et al.Current Hematology Reports|August 7, 2003
Deep venous thrombosis in the medically illWalter Ageno, Alexander G TurpieGeriatrics|September 1, 1989
Urinary incontinence: current overview of a prevalent problemI D Turpie, J SkellyPageof 1,948